Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990

Neurology

Volumn 49, Issue 5, 1997, Pages 1284-1288

  Bower, James H ^a   Maraganore, Demetrius M ^a   McDonnell, Shannon K ^a   Rocca, Walter A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SURVIVAL; UNITED STATES;

EID: 0030695277     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.5.1284     Document Type: Article

References (29)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogenous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
2. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
3. Dejerine J, Thomas A. L'atrophie olivo-ponto-cérébelleuse. Nouv Iconog Salpetriere 1900;13:330-370.
4. Shy GM, Drager GA. A neurological syndrome associated with orthostatic hypotension. Arch Neurol 1960;2:511-527.
5. Adams R, van Bogaert L, van der Eecken H. Dégénérescences nigro-striées et cerebello-nigro-striées. Psychiatr Neurol 1961; 142:219-259.
6. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-274.
7. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173.
8. Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996;46:1470.
9. de Rijk MC, Tzourio C, Breteler MMB, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON Collaborative Study. J Neurol Neurosurg Psychiatry 1997;62:10-15.
10. Anderson DW, Mantel N. On epidemiologic surveys. Am J Epidemiol 1983;118:613-619.
11. Deming WE. Boundaries of statistical inference. In: Johnson NL, Smith H Jr, eds. New developments in survey sampling. New York: John Wiley & Sons, 1969:652-670.
12. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. Mastaglia FL, Grainger K, Kee F, Sadka M, Lefroy R. Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome) clinical and electrophysiological observations in eleven cases. Proc Aust Assoc Neurol 1973;10:35-44.
14. Radhakrishnan K, Thacker AK, Maloo JC, Gerryo SE, Mousa ME. Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology 1988;7:159-164.
15. Golbe LI. The epidemiology of progressive supranuclear palsy. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S, eds. Advances in neurology. Vol. 69. Philadelphia: Lippincott-Raven, 1996:25-31.
16. Golbe LI. The epidemiology of PSP. J Neural Transm 1994; 42(suppl):263-273.
17. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-1034.
18. Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol 1984;16:278-282.
19. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-1008.
20. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991;18:275-278.
21. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
22. Kristensen MØ. Progressive supranuclear palsy-20 years later. Acta Neurol Scand 1985;71:177-189.
23. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;61:615-620.
24. Daniel SE, de Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118: 759-770.
25. Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-298.
26. Jackson JA, Jankovic J, Ford J. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol 1983;13:273-278.
27. Wenning GK, Ben Shlomo Y, Magalhães M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-845.
28. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;(suppl):78-89.
29. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. London: Butterworths, 1994:262-281.